Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme

Glioblastoma multiforme (GBM) is the most common and aggressive malignant adult primary brain tumor. Despite surgical resection followed by radiotherapy and chemotherapy, the median survival rate is approximately 14 months. Although experimental therapies are in clinical trials for GBM, there is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Sze Kiat, Pastori, Chiara, Penas, Clara, Komotar, Ricardo J., Ivan, Michael E., Wahlestedt, Claes, Ayad, Nagi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861620/
https://www.ncbi.nlm.nih.gov/pubmed/29558959
http://dx.doi.org/10.1186/s12943-018-0822-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861620/
https://www.ncbi.nlm.nih.gov/pubmed/29558959
http://dx.doi.org/10.1186/s12943-018-0822-0

Ejemplares similares